Publications
Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine.
2020
Int J Tuberc Lung Dis
Butov D, Lange C, Heyckendorf J, et al.
DOI:
10.5588/ijtld.19.0508
Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study.
2020
Eur Respir J
Basu Roy R, Thee S, Blázquez-Gamero D, et al.
DOI:
10.1183/13993003.02004-2019
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.
2019
Eur Respir J
van Leth F, Brinkmann F, Cirillo DM, et al.
DOI:
10.1183/13993003.02089-2018
Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study.
2019
Open Forum Infect Dis
Sane Schepisi M, Navarra A, Altet Gomez MN, et al.
DOI:
10.1093/ofid/ofy337
Tuberculosis disease in children and adolescents on therapy with anti-tumor necrosis factor-alpha agents: a collaborative, multi-centre ptbnet study.
2019
Clin Infect Dis
Noguera-Julian A, Calzada-HernÁndez J, Brinkmann F, et al.
DOI:
10.1093/cid/ciz1138
Clofazimine does not lead to significant QT interval prolongation: a multicentre study.
2018
Eur Respir J
Zweijpfenning SMH, van Groningen H, van Ingen J, et al.
DOI:
10.1183/13993003.01386-2018
Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe.
2018
Eur Respir J
Villanueva P, Neth O, Ritz N, et al.
DOI:
10.1183/13993003.00346-2018
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.
2018
Eur Respir J
van Ingen J, Aksamit T, Andrejak C, et al.
DOI:
10.1183/13993003.00170-2018
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.
2018
Am J Respir Crit Care Med
Günther G, van Leth F, Alexandru S, et al.
DOI:
10.1164/rccm.201710-2141OC
QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study.
2018
Eur Respir J
Guglielmetti L, Tiberi S, Burman M, et al.
DOI:
10.1183/13993003.00537-2018
Tackling the MDR-TB epidemic in Ukraine: every little helps … and much more needed.
2018
J Public Health (Oxf)
Burman M, Nikolayevskyy V, Kontsevaya I, et al.
DOI:
10.1093/pubmed/fdx014
Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.
2017
Am J Respir Crit Care Med
van Leth F, Günther G, Hoffmann H, et al.
DOI:
10.1164/rccm.201705-0995LE
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases.
2017
Eur Respir J
van Ingen J, Wagner D, Gallagher J, et al.
DOI:
10.1183/13993003.01855-2016
Management of child MDR-TB contacts across countries in the WHO European Region: a survey of current practice.
2017
Int J Tuberc Lung Dis
Turkova A, Tebruegge M, Brinkmann F, et al.
DOI:
10.5588/ijtld.16.0949
Treatment outcomes of MDR-TB and HIV co-infection in Europe.
2017
Eur Respir J
Magis-Escurra C, Günther G, Lange C, et al.
DOI:
10.1183/13993003.02363-2016